| |
| |
|
| Insider
Information: |
Curnutte John T |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
130,934 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,832,858 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
130,934 |
|
|
| Total
Value |
$1,832,858 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Portola Pharmaceuticals Inc |
PTLA |
EVP R&D |
2019-05-20 |
101,656 |
2014-06-16 |
0 |
Premium* |
|
|
Pliant Therapeutics, Inc. |
PLRX |
Director |
2020-06-02 |
29,278 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2014-06-16 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2014-06-16 |
4 |
AS |
$26.00 |
$259,970 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2014-06-17 |
4 |
OE |
$8.50 |
$170,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2014-06-17 |
4 |
AS |
$27.00 |
$550,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2014-06-18 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2014-06-18 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-13 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-13 |
4 |
AS |
$32.50 |
$325,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-17 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-17 |
4 |
AS |
$35.00 |
$350,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-18 |
4 |
AS |
$37.50 |
$375,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-18 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-23 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-02-23 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-05-28 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-05-28 |
4 |
AS |
$40.20 |
$402,980 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-05-29 |
4 |
AS |
$42.50 |
$425,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-05-29 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-06-16 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-06-16 |
4 |
AS |
$45.00 |
$450,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-06-22 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-06-22 |
4 |
AS |
$47.50 |
$475,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-07-15 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2015-07-15 |
4 |
AS |
$50.00 |
$500,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
